Back to Results

E4512: A Randomized Phase III Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Observation for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein

Study category: Cancer

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Type of Study

Treatment

Location

Rocky Mountain Regional VA Medical Center

Principal Investigator
Jessica Mcdermott,  MD

Jessica Mcdermott, MD

Study ID

Protocol Number: 19-1694

More information available at ClinicalTrials.gov: NCT02201992

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers